Morgan Stanley raises Johnson & Johnson price target to $294

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Morgan Stanley analyst Terence Flynn maintained an Overweight rating on Johnson & Johnson and raised the price target to $294 from $284.

powered bylight_fuzz_icon
45760030

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on Johnson & Johnson and raised the price target to $294 from $284. The revised target suggests increased confidence in the company's valuation potential following the adjustment.

The rating action reflects an updated assessment of the stock's performance outlook. Johnson & Johnson continues to be viewed favorably within the analyst's coverage universe, as evidenced by the retention of the Overweight designation alongside the higher price objective.

What specific factors drove Morgan Stanley to increase the price target for Johnson & Johnson?

How might this rating upgrade influence investor sentiment toward Johnson & Johnson in the short term?

What are the potential risks that could prevent Johnson & Johnson from reaching the new $294 price target?

like15
dislike

Johnson & Johnson and TIME launch Healthcare Champion award

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Johnson & Johnson and TIME have introduced the Healthcare Champion of the Year award to honor U.S. healthcare professionals for their contributions to patient care, innovation, and grit. Nominations are open from July 16, 2026, to August 28, 2026, with the winner to be announced before December 9, 2026.

powered bylight_fuzz_icon
45753633

*this image is generated using AI for illustrative purposes only.

Johnson & Johnson and TIME have launched the Healthcare Champion of the Year award to recognize healthcare professionals in the United States. The new branded award aims to honor individuals whose care, innovation, and grit are driving health system change to advance better care for all. The honoree will be announced leading up to TIME’s "A Year in TIME" celebration on December 9, 2026, in New York City.

Nominations for the inaugural award will open on July 16, 2026, and close at 5:00 p.m. ET on August 28, 2026. The winner will be selected by Johnson & Johnson and a panel of industry experts. Eligible nominees include physicians, nurses, advanced practice clinicians, surgeons, community health workers, care navigators, and other healthcare professionals actively involved in clinical care or care delivery in the United States.

Recognizing Healthcare Leaders

The award seeks to spotlight healthcare leaders who are strengthening care amid growing pressure on health systems. Nominees may be at any stage of their career and should demonstrate real-world impact by how they show up for patients, colleagues, and communities. Nominations should reflect at least one of the program’s core themes: grit, innovation, or patient care.

Commitment to Health Workforce

The recognition builds on Johnson & Johnson’s long-standing commitment to improving health outcomes by championing nursing and a thriving health workforce. Through J&J CareCommunity, the company’s global social impact platform, Johnson & Johnson helps equip nurses and community health workers with the skills, resources, and connections they need to strengthen health systems and expand access to care.

Nomination Timeline

Event Date
Nominations Open July 16, 2026
Nominations Close 5:00 p.m. ET on August 28, 2026
Winner Announcement Before December 9, 2026

Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson, said the award recognizes those whose compassion, innovation, and grit are transforming patient care today and building a healthier tomorrow.

Will this award become an annual recurring event beyond 2026?

How will Johnson & Johnson leverage the winner's innovations within its own business strategies?

Could this partnership signal a broader trend of increased corporate sponsorship in healthcare recognition?

like20
dislike

More News on Johnson & Johnson